Results 21 to 30 of about 3,514 (173)

The Complexities and Challenges of Managing Genetic Causes of Hyperphosphataemia, a Case Report. [PDF]

open access: yesJ Paediatr Child Health
Journal of Paediatrics and Child Health, Volume 61, Issue 8, Page 1332-1337, August 2025.
Rodrigues F   +3 more
europepmc   +2 more sources

Whitish Deposits in the Stomach and Duodenum. [PDF]

open access: yesUnited European Gastroenterol J
United European Gastroenterology Journal, Volume 13, Issue 10, Page 1913-1915, December 2025.
Yang KY, Zhou XJ, Xie W.
europepmc   +2 more sources

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification

open access: yesFrontiers in Cardiovascular Medicine, 2021
Objective: Sevelamer hydrochloride is a phosphate binder used to treat hyperphosphatemia in chronic kidney disease (CKD) patients that can reduce valvular and vascular calcification. The aim of this study was to examine the effects of sevelamer treatment
Zhen Meng   +5 more
doaj   +1 more source

Comparison of sevelamer and calcium carbonate in prevention of hypomagnesemia in hemodialysis patients

open access: yesInternational Journal of Preventive Medicine, 2021
Background: Chronic kidney disease (CKD) is a life-threatening disease with numerous complications. Hemodialysis (HD) patients are prone to magnesium deficiency due to malnutrition, which can cause cardiovascular complications and increase mortality. The
Elahe Jandaghi   +5 more
doaj   +1 more source

Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial

open access: yesToxins, 2021
P-cresyl sulfate and indoxyl sulfate are strongly associated with cardiovascular events and all-cause mortality in chronic kidney disease (CKD). This randomized controlled trial was conducted to compare the effects between sevelamer and calcium carbonate
Kullaya Takkavatakarn   +10 more
doaj   +1 more source

The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy [PDF]

open access: yesJournal of Nephropathology, 2018
Background: Diabetic nephropathy (DN) is one of the major complications of diabetes. Hyperglycemia, inflammation and oxidative stress as well as advanced glycation end products (AGEs) are reported as the risk factors for DN. Sevelamer has shown promising
Sosan Mohammadi Kebar   +5 more
doaj   +1 more source

Case report: Sevelamer-associated colitis—a cause of pseudotumor formation with colon perforation and life-threatening bleeding

open access: yesFrontiers in Medicine, 2023
Chronic kidney disease (CKD) is a very common chronic non-communicable disease. Phosphate and calcium metabolism disorders are one of the most common features of CKD.
Margareta Fistrek Prlic   +13 more
doaj   +1 more source

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients [PDF]

open access: yes, 2009
Sevelamer hydrochloride (HCl), a calcium-free phosphate binder, is increasingly used due to concerns related to calcium exposure and the development of vascular calcifications.
Amin, Nimisha   +9 more
core   +1 more source

Binding interactions with sevelamer and polystyrene sulfonate in vitro [PDF]

open access: yes, 2021
This study explored the binding of 28 drugs, which were selected based on frequency of concomitant use and chemical properties, to sevelamer and polystyrene sulfonate in vitro.
Jansman, Frank G.A.   +13 more
core   +1 more source

Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis [PDF]

open access: yesJournal of Nephropathology
Introduction: Hyperphosphatemia is an independent risk factor for mortality in chronic kidney disease (CKD) patients. Objectives: This systematic review and meta-analysis aimed to investigate the effect of Sevelamer on serum phosphorus levels in CKD and ...
Farshad Gharebakhshi   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy